Prostate Cancer - Results from #27100

Low risk prostate cancer in men ≥ 70 years old: To treat or not to treat - Abstract September 20, 2011

Endorectal balloon reduces anorectal doses in post-prostatectomy intensity-modulated radiotherapy - Abstract September 20, 2011

Long-term biochemical control of prostate cancer after standard or hyper-fractionation: Evidence for different outcomes between low-intermediate and high risk patients - Abstract September 20, 2011

Prostate cancer: Prediction of biochemical failure after external-beam radiation therapy-- Kattan nomogram and endorectal MR imaging estimation of tumor volume - Abstract September 20, 2011

A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy - Abstract September 20, 2011

Efficacy of alternative antiandrogen therapy for prostate cancer that relapsed after initial maximum androgen blockade - Abstract September 19, 2011

Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody - Abstract September 19, 2011

Heregulin expression and prognosis in prostate adenocarcinoma - Abstract September 19, 2011

Dietary acrylamide and risk of prostate cancer - Abstract September 19, 2011

Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis - Abstract September 19, 2011

Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: A case report - Abstract September 19, 2011

Transition zone PSA density improves the prostate cancer detection rate both in PSA 4.0-10.0 and 10.1-20.0 ng/ml in Chinese men - Abstract September 19, 2011

Circulating and disseminated tumor cells in the management of advanced prostate cancer - Abstract September 19, 2011

Does the transrectal ultrasound probe influence prostate cancer detection in patients undergoing an extended prostate biopsy scheme? Results of a large retrospective study - Abstract September 19, 2011

Genetics may explain why calcium increases risk for prostate cancer September 19, 2011

Prostate cancer can be detected even in patients with decreased PSA less than 2.5 ng/ml after treatment of chronic prostatitis - Abstract September 16, 2011

Are we worrying about the right men and are the right men feeling worried? Conscious but not unconscious prostate anxiety predicts screening among men from three ethnic groups - Abstract September 16, 2011

Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: Diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging - Abstract September 16, 2011

Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study - Abstract September 16, 2011

Clinical trial update and novel therapeutic approaches for metastatic prostate cancer - Abstract September 16, 2011

Page 1356 of 1436